Hydrazone amide derivatives and use thereof in preparation of anti-osteoporosis drugs

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12252459
APP PUB NO 20220153688A1
SERIAL NO

17562040

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are a new class of hydrazone amide derivatives and the use thereof in the preparation of anti-osteoporosis drugs, wherein the structural formula of the hydrazone amide derivative is as shown in formula (I), and same are a new class of compounds with an anti-osteoporosis effect.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT CO LTDSHENZHEN GUANGDONG 518108

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gu, Qiong Guangdong, CN 5 1
Huang, Dane Guangdong, CN 2 0
Xu, Jun Guangdong, CN 1004 7793
Zhao, Chao Guangdong, CN 139 838

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 18, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 18, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 18, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00